2 results match your criteria: "Gynecologic Cancer Institute of Chicago[Affiliation]"
Gynecol Oncol Rep
February 2022
Gynecologic Cancer Institute of Chicago, Oak Lawn, IL 60453, United States.
Mullerian adenosarcomas are rare and often low-grade mixed tumors that typically respond well to optimal surgical resection. However, adenosarcoma with sarcomatous overgrowth (ASSO) is a high-grade mixed tumor commonly associated with invasion, metastasis, and a poor prognosis. The health care providers herein report a case study of a patient diagnosed with ASSO who has maintained remission status for 19 months following radical surgical resection alone.
View Article and Find Full Text PDFGynecol Oncol Rep
November 2015
Gynecologic Cancer Institute of Chicago, 5716 W 95th Street, Oak Lawn, IL 60453, United States.
•Bevacizumab was an effective agent in one case of advanced uterine PNET.•VEGF was expressed by the tumor, supporting a mechanism for effectiveness.•Cisplatin/etoposide/bevacizumab should be further studied in clinical trials.
View Article and Find Full Text PDF